Strata Critical Medical, Inc. SRTA
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 66.75% | 29.62% | 2.73% | -17.86% | -35.60% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 66.75% | 29.62% | 2.73% | -17.86% | -35.60% |
| Cost of Revenue | 62.79% | 29.74% | 3.21% | -16.21% | -33.30% |
| Gross Profit | 84.09% | 29.17% | 0.84% | -24.00% | -44.05% |
| SG&A Expenses | -3.25% | -22.96% | -32.93% | -35.05% | -37.97% |
| Depreciation & Amortization | 430.02% | 166.87% | 167.73% | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 46.84% | 12.89% | -8.68% | -22.93% | -35.17% |
| Operating Income | 62.10% | 70.01% | 63.71% | 47.85% | 32.66% |
| Income Before Tax | -28.11% | 38.13% | 29.96% | 60.65% | 63.94% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -28.11% | 38.25% | 29.88% | 59.90% | 63.27% |
| Earnings from Discontinued Operations | 7,103.31% | 11,141.33% | 4,588.02% | 1,601.47% | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 311.88% | 276.90% | 251.42% | 178.49% | 61.43% |
| EBIT | 62.10% | 70.01% | 63.71% | 47.85% | 32.66% |
| EBITDA | 118.79% | 90.27% | 75.02% | 49.81% | 33.29% |
| EPS Basic | 306.85% | 268.35% | 242.90% | 170.79% | 63.29% |
| Normalized Basic EPS | 72.81% | 70.16% | 65.79% | 1.13% | -4.95% |
| EPS Diluted | 301.89% | 263.38% | 237.15% | 168.88% | 63.08% |
| Normalized Diluted EPS | 72.81% | 70.16% | 65.79% | 1.13% | -4.71% |
| Average Basic Shares Outstanding | 6.58% | 6.27% | 5.92% | 5.22% | 5.12% |
| Average Diluted Shares Outstanding | 8.11% | 7.81% | 5.92% | 5.22% | 2.78% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |